Metraipolis › archive › dc_52fef2516cfa

Prognostic Implications of Vancomycin Therapeutic Drug Monitoring for Critically Ill Stroke Patients: Evidence From a Subtype-Oriented Analysis — Europe PMC PMID:41711398

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41711398
DOI
10.1002/cns.70799
License (as archived)
solo-consultazione
Archived
2026-11-06T08:43:40.353Z
SHA-256 of the archived text
88d4f5e80d3f6d5a38774b06466d9182393042b92a3211c757771dd876da602b
Stable URL of this page
https://metraipolis.com/documento/dc_52fef2516cfa

How to cite

Prognostic Implications of Vancomycin Therapeutic Drug Monitoring for Critically Ill Stroke Patients: Evidence From a Subtype-Oriented Analysis — Europe PMC PMID:41711398 — Europe PMC (en), https://europepmc.org/article/MED/41711398 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_52fef2516cfa (Metraipolis archive dc_52fef2516cfa, sha256 88d4f5e80d3f6d5a38774b06466d9182393042b92a3211c757771dd876da602b)
BibTeX
@misc{dc52fef2516cfa,
  title = {Prognostic Implications of Vancomycin Therapeutic Drug Monitoring for Critically Ill Stroke Patients: Evidence From a Subtype-Oriented Analysis — Europe PMC PMID:41711398},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41711398},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_52fef2516cfa; sha256 88d4f5e80d3f6d5a38774b06466d9182393042b92a3211c757771dd876da602b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41711398. Agents can read the archived copy with the MCP tool read_document.